SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-174261
Filing Date
2021-05-27
Accepted
2021-05-27 06:52:07
Documents
13
Period of Report
2021-05-27
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d175510d8k.htm   iXBRL 8-K 34672
  Complete submission text file 0001193125-21-174261.txt   225581

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA lly-20210527.xsd EX-101.SCH 5584
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lly-20210527_def.xml EX-101.DEF 15573
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lly-20210527_lab.xml EX-101.LAB 26527
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lly-20210527_pre.xml EX-101.PRE 16866
6 EXTRACTED XBRL INSTANCE DOCUMENT d175510d8k_htm.xml XML 11704
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06351 | Film No.: 21968482
SIC: 2834 Pharmaceutical Preparations